GOP Eyeing Medicaid Work Requirements For ‘Early 2027’

House Majority Leader Steve Scalise (R-La.) said Monday that Republicans are eyeing early 2027 as the target date for the new Medicaid work requirements in the large budget package intended to advance and solidify President Trump’s agenda. The timeline for the bill’s new work requirements remains up in the air, as Republican leadership continues to negotiate with warring factions ...

Read More

Newsom’s Pitch as He Seeks To Pare Down Immigrant Health Care: ‘We Have To Adjust’

Gov. Gavin Newsom on Wednesday proposed that California roll back health care for immigrants without legal status, saying the state needed to cut benefits for some to maintain core services across the board. It’s a striking reversal for the Democrat, who had promised universal health care and called health coverage for immigrants the moral and ethical thing to ...

Read More

Double Blow: Drug Tariffs and Wage Hikes Threaten California’s Pharmacies

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man’s defensive wall in a tariff war. Independent pharmacist Benjamin Jolley and his colleagues worry that the tariffs, aimed at bringing drug production to the United States, could instead drive companies out of business ...

Read More

Gavin Newsom Says These Middlemen Drive Up Drug Prices. He’s Got A New Plan To Fix It

Gov. Gavin Newsom will seek to regulate prescription drug intermediaries, eight months after vetoing a similar bill.

Read More

California Medical Association Condemns Governor’s Plan To Divert Voter-Approved Health Care Funds

Governor Newsom’s revised budget proposal diverts funding from voter-approved Prop 35 and Prop 56 health care funds to backfill the state’s deficit—violating voter intent and threatening access to care for millions of Medi-Cal patients. CMA is urging legislators to reject the proposal.

Read More

Hospitals Cheer Judge’s 340B Rebate Ruling But Still Await HHS’ Final Say

Hospital groups are celebrating a federal judge’s initial ruling against pharmaceutical makers who contended a government block on 340B Drug Pricing Program rebate models was unlawful. Judge Dabney Friedrich, of the U.S. District Court for the District of Columbia, on Thursday denied motions for summary judgment brought by drugmakers Eli Lilly, Bristol Myers Squibb and ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square